Gene therapy - New challenges ahead

被引：86

作者：

Williams, DA ^{[1
]}

Baum, C

机构：

[1] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA

[2] Hannover Med Sch, Dept Hematol & Oncol, D-3000 Hannover, Germany

来源：

SCIENCE | 2003年 / 302卷 / 5644期

关键词：

D O I：

10.1126/science.1091258

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：400 / 401

页数：2

共 9 条

[1] Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning [J].

Aiuti, A ;

Slavin, S ;

Aker, M ;

Ficara, F ;

Deola, S ;

Mortellaro, A ;

Morecki, S ;

Andolfi, G ;

Tabucchi, A ;

Carlucci, F ;

Marinello, E ;

Cattaneo, F ;

Vai, S ;

Servida, P ;

Miniero, R ;

Roncarolo, MG ;

Bordignon, C .

SCIENCE, 2002, 296 (5577) :2410-2413

[2] Side effects of retroviral gene transfer into hematopoietic stem cells [J].

Baum, C ;

Düllmann, J ;

Li, ZX ;

Fehse, B ;

Meyer, J ;

Williams, DA ;

von Kalle, C .

BLOOD, 2003, 101 (06) :2099-2114

[3] Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy [J].

Hacein-Bey-Abina, S ;

Le Deist, F ;

Carlier, F ;

Bouneaud, C ;

Hue, C ;

De Villartay, JP ;

Thrasher, AJ ;

Wulffraat, N ;

Sorensen, R ;

Dupuis-Girod, S ;

Fischer, A ;

Cavazzana-Calvo, M ;

Davies, EG ;

Kuis, W ;

Lundlaan, WHK ;

Leiva, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (16) :1185-1193

[4] LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [J].

Hacein-Bey-Abina, S ;

Von Kalle, C ;

Schmidt, M ;

McCcormack, MP ;

Wulffraat, N ;

Leboulch, P ;

Lim, A ;

Osborne, CS ;

Pawliuk, R ;

Morillon, E ;

Sorensen, R ;

Forster, A ;

Fraser, P ;

Cohen, JI ;

de Saint Basile, G ;

Alexander, I ;

Wintergerst, U ;

Frebourg, T ;

Aurias, A ;

Stoppa-Lyonnet, D ;

Romana, S ;

Radford-Weiss, I ;

Gross, F ;

Valensi, F ;

Delabesse, E ;

Macintyre, E ;

Sigaux, F ;

Soulier, J ;

Leiva, LE ;

Wissler, M ;

Prinz, C ;

Rabbitts, TH ;

Le Deist, F ;

Fischer, A ;

Cavazzana-Calvo, M .

SCIENCE, 2003, 302 (5644) :415-419

[5] American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells [J].

Kohn, DB ;

Sadelain, M ;

Dunbar, C ;

Bodine, D ;

Kiem, HP ;

Candotti, F ;

Tisdale, J ;

Riviére, I ;

Blau, CA ;

Richard, RE ;

Sorrentino, B ;

Nolta, J ;

Malech, H ;

Brenner, M ;

Cornetta, K ;

Cavagnaro, J ;

High, K ;

Glorioso, J .

MOLECULAR THERAPY, 2003, 8 (02) :180-187

[6] Murine leukemia induced by retroviral gene marking [J].

Li, ZX ;

Düllmann, J ;

Schiedlmeier, B ;

Schmidt, M ;

von Kalle, C ;

Meyer, J ;

Forster, M ;

Stocking, C ;

Wahlers, A ;

Frank, O ;

Ostertag, W ;

Kühlcke, K ;

Eckert, HG ;

Fehse, B ;

Baum, C .

SCIENCE, 2002, 296 (5567) :497-497

[7] Polyclonal long-term repopulating stem cell clones in a primate model [J].

Schmidt, M ;

Zickler, P ;

Hoffmann, G ;

Haas, S ;

Wissler, M ;

Muessig, A ;

Tisdale, JF ;

Kuramoto, K ;

Andrews, RG ;

Wu, T ;

Kiem, HP ;

Dunbar, CE ;

von Kalle, C .

BLOOD, 2002, 100 (08) :2737-2743

[8] HIV-1 integration in the human genome favors active genes and local hotspots [J].

Schröder, ARW ;

Shinn, P ;

Chen, HM ;

Berry, C ;

Ecker, JR ;

Bushman, F .

CELL, 2002, 110 (04) :521-529

[9] Transcription start regions in the human genome are favored targets for MLV integration [J].

Wu, XL ;

Li, Y ;

Crise, B ;

Burgess, SM .

SCIENCE, 2003, 300 (5626) :1749-1751

← 1 →